Comparison of Intraocular Pressure Measurement With the Novel TonoVera Device With Other Commonly Used Devices

ConditionGlaucoma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorState University of New York at Buffalo

About this trial

We are testing the accuracy of Reichert's Tono-Vera tonometer by comparing measurements of IOP with this device and measurements with other commonly-used tonometers, including Goldmann Applanation and iCare.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Ability to provide signed and dated informed consent form. Patients willing to comply with all study procedures and be available for the duration of the study.

Disqualifiers

Patients age less than 18 years Patients unable or unwilling to provide informed consent to participate in the study Patients for which an accurate tonometry reading cannot be performed. This may include those with blepharospasm (lid squeezers), nystagmus, extensive corneal pathology, or contact lens wearers who cannot remove their contact lens.Patients with significant scleral thinning Patients with a known allergy to proparacaine or fluorescein as these are used to anesthetize and allow measurement respectively of the eye when used with the Goldmann tonometer.

Trial design

Design model

Single group

Treatments tested in this trial

  • Tono-Vera tonometer

    Device

    The tonometer measures intraocular pressure with a small rebound probe, similar to those used with other tonometers currently on the market, such as the iCare.

  • Goldman Applanation Tonometry

    Device

    This is the current gold standard for measuring eye pressure.

Treatment groups

300 Participants
are divided into 1 treatment group
Group A: IOP MeasurementOther 2 interventions

Trial outcomes

Primary outcomes

1

Intraocular Pressure

pressure inside the eye

Time frame
Baseline only

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.